COMMUNIQUÉS West-GlobeNewswire

AFA: Signing of New RAISE Family Caregiver Law Positive Step, But Continued Action Needed from Washington
23/01/2018
NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA) heralded the signing of the new RAISE Family Caregiver Act, which will provide a desperately needed comprehensive national plan for [...]
K2M Group Holdings, Inc. to Release Fourth Quarter and Fiscal Year 2017 Financial Results on February 28th
23/01/2018
LEESBURG, Va., Jan. 23, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
Cocrystal Pharma Announces 1-for-30 Reverse Stock Split
23/01/2018
– Reverse stock split positions Company to uplist to the NASDAQ Capital Market in Q1 2018 – – Company expects to commence Phase 2a study in Q1 2018 for lead program, CC-31244, for the treatment of hepatitis C infection [...]
Obalon Announces Termination of Public Offering of Common Stock
23/01/2018
SAN DIEGO, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (the “Company” or “Obalon”) (NASDAQ: OBLN ) today announced the termination of the underwriting agreement and cancellation of its previously [...]
AXIM Biotech Announces Successful Completion of Exploratory Meeting with the Dutch Medicines Evaluation Board on MedChew Rx Program for Treatment of Pain and Spasticity in MS Patients
23/01/2018
NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM), the world leader in cannabinoid research and development, announced today that it has successfully completed an exploratory meeting [...]
Data on Novel Humanized Models for Targeted Immunotherapy Development, a CrownBio Conference Talk on January 24th, 2018
23/01/2018
SAN DIEGO, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]
Solon Eiendom ASA : Primary insider notification
23/01/2018
(Oslo, Norway, 23 January 2018) Solon Eiendom ASA Chairman of the Board Simen Thorsen (through his wholly owned company Hortulan AS) has today bought 21,481 shares in Solon Eiendom ASA at a price of NOK 21.404 per share [...]
Cannabix Technologies Provides Update on Marijuana Breathalyzer Development
23/01/2018
VANCOUVER, British Columbia, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK:BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and [...]
Agritek Holdings, Inc. Announces National Feature Interview As Public Cannabis Company On Fox Business Network To Air Nationally January 28th, 2018
23/01/2018
LOS ANGELES, CA, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Agritek Holdings, Inc. (OTCQB: AGTK) www.AgritekHoldings.com , a fully integrated, active cannabis real estate investor and branding consultant in the legal cannabis [...]
Hemispherx Comments on $500+ Million Market Opportunity for Ampligen®, the Only Late Stage ME/CFS Candidate in the U.S.
23/01/2018
ORLANDO, Fla., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), focused on pharmaceutical research, today commented on the overall market opportunity for its Ampligen ® drug candidate in [...]
Progressive Care Ends Agreement with Boustead Securities
23/01/2018
MIAMI, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of [...]
Zealand Pharma to present Phase 2 results on glepaglutide at the ASPEN 2018 Conference in Las Vegas, U.S.
23/01/2018
Company announcement - No. 6/2018 Zealand Pharma to present Phase 2 results on glepaglutide at the ASPEN 2018 Conference in Las Vegas, U.S. Glepaglutide is in development as a potential new treatment for patients with [...]
Avid Bioservices to Present at NobleCon14
23/01/2018
TUSTIN, Calif., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ), a company working to improve patient lives by providing high quality biologics manufacturing services to [...]
Quotient Limited to Report Fiscal Third Quarter 2018 Financial Results and Host Conference Call
23/01/2018
JERSEY, Channel Islands, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31 [...]
Hooper Holmes Announces Rebrand to Provant Health
23/01/2018
OLATHE, Kan., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Hooper Holmes, Inc. (OTCQX:HPHW), the largest publicly-traded, pure-play well-being leader in workplace population health and clinical research support services, today [...]
Akari Therapeutics Strengthens Board with Two Senior Industry Appointments
23/01/2018
NEW YORK and LONDON, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ: AKTX ) (“Akari” or “the Company”), a biopharmaceutical company focused on the development and commercialization of innovative [...]
Altimmune Announces Notice of Allowance on Patent Covering Use of NasoShield in the U.S.
23/01/2018
Patent Will Specifically Cover Prophylactic and Post-Exposure Use of NasoShield in the U.S. Patents with Similar Protection Already Issued in Europe and Japan GAITHERSBURG, Md., Jan. 23, 2018 (GLOBE NEWSWIRE) -- [...]
BioCanCell Announces Terms of $25 Million Funding Round
23/01/2018
JERUSALEM, Jan. 23, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE: BICL ) (the “Company") , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to [...]
Nephros to Present at NobleCon14
23/01/2018
SOUTH ORANGE, N.J., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid- [...]

Pages